<DOC>
	<DOCNO>NCT00135369</DOCNO>
	<brief_summary>The purpose study demonstrate virologically control HIV-infected individual successfully switch standard-of-care regimen dose twice-daily frequently simple once-daily ( QD ) regimen maintain virologic control , evaluate proportion subject continue plasma HIV-1 level &lt; 50 copies/mL switch QD regimen .</brief_summary>
	<brief_title>Switching HIV-1 Infected Subjects From Highly Active Anti-Retroviral Treatment ( HAART ) Regimen Dosed Twice Daily More Frequently Once-Daily Regimen</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Stavudine</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>Documented HIV infection 18 year age old weigh least 40 kg Two plasma HIV RNA level limit quantification ( one least 90 day prior screen visit one within 30 day patient baseline visit ) Currently receive standardofcare HAART regimen least one agent dose twicedaily frequently Pregnancy , breastfeed plan become pregnant study period Any prior document virologic failure one HAART regimens Active AIDSdefining opportunistic infection disease Proven suspect acute hepatitis within 30 day prior study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>HIV-AIDS</keyword>
</DOC>